Beckman Coulter just announced latest recall notice
Scotty is to be recalled to higher service
Beckman Coulter just announced latest recall notice
Scotty is to be recalled to higher service
Date Posted: August 11, 2010
Recall Number: Z-2208-2010
Product: Access Immunoassay Systems AFP QC, Part Number: 33219
Code Information Lot Numbers: 911158, 911581, and 917631
by Morningstar Credit Committee | 08-19-10 | 4:24AM
"After a heart-stopping drop of 15%, we took a position in Beckman Coulter (BEC). Because we're confident that BEC will fall further, we implemented the first of 3 purchases that we're expecting to make. We're ready and excited to make the next two purchases if they happened to be triggered at much lower levels"
Beckman Coulter today announced a record contract with CML HealthCare ("CML") of Toronto, Canada. According to the company, the deal represents the largest contract of any Canadian diagnostics company for a single testing site.
SG, Beckman Coulter, makes "Mad Money" Jim Cramer's List of the Worst CEOs
Source Beckman web site - Diagnostics Today Online July 1, 2009
Customer Perceptions Shape New Brand
Beckman Coulter's New Brand Position Demonstrates True Partnership
"We're Better Together is a positive expression of a shared commitment with our customers to optimizing patient care and reducing the cost of care," says Scott Garrett, chairman, president and CEO of Beckman Coulter.
Remember when the DxN was going to be the future of BC. Could it be pure B*** S*** to lure in a private capital buy out?
If you take away anything from the below about the DxN
....schedule for launch in 2010
....we don’t want to do anything that would slow down or delay the launch date on the DxN
Class 2 RecallUnicel DxH 800 Coulter Cellular Analysis System
Date Posted June 25, 2010 Recall Number Z-1905-2010 Product Unicel DxH 800 Coulter Cellular Analysis System,
(From SmarTrend 6/14/2010)
When Beckman Coulter (NYSE:BEC) reported earnings 44 days ago on April 28, 2010, analysts, on average, expected the company to report earnings of $0.85 on sales of $879 million.
The company actually reported EPS of $0.86 on sales of $881 million, beating EPS estimates by $0.01 and beating revenues estimates by $2 million.